Show simple item record

dc.contributor.authorMacLeod, Angus D.
dc.contributor.authorGoddard, Hannah
dc.contributor.authorCounsell, Carl E.
dc.date.accessioned2016-05-26T10:40:07Z
dc.date.available2016-05-26T10:40:07Z
dc.date.issued2016-07
dc.identifier.citationMacLeod , A D , Goddard , H & Counsell , C E 2016 , ' Co-morbidity burden in Parkinson’s disease : Comparison with controls and its influence on prognosis ' , Parkinsonism & Related Disorders , vol. 28 , pp. 124-129 . https://doi.org/10.1016/j.parkreldis.2016.05.013en
dc.identifier.issn1353-8020
dc.identifier.otherPURE: 66682600
dc.identifier.otherPURE UUID: 750801a2-adcd-4ea4-acbb-07f33e2f59a1
dc.identifier.otherScopus: 84974829824
dc.identifier.urihttp://hdl.handle.net/2164/6015
dc.descriptionFinancial support This study was funded by Parkinson’s UK, the Scottish Chief Scientist Office, NHS Grampian endowments, the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, and SPRING. The funders had no involvement in the study. Acknowledgements We acknowledge funding for the PINE study from Parkinson’s UK (G-0502, G-0914, G-1302), the Scottish Chief Scientist Office(CAF/12/05), the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, NHS Grampian endowments and SPRING. We thank the patients and controls for their participation and the research staff who collected data and supported the study database.en
dc.format.extent6
dc.language.isoeng
dc.relation.ispartofParkinsonism & Related Disordersen
dc.rights© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).en
dc.subjectParkinson’s diseaseen
dc.subjectco-morbidityen
dc.subjectCharlsonen
dc.subjectmortalityen
dc.subjectdependencyen
dc.subjectRC Internal medicineen
dc.subjectParkinson's UKen
dc.subjectG-0502en
dc.subjectG-0914en
dc.subjectG-1302en
dc.subjectChief Scientist Office (CSO)en
dc.subjectCAF/12/05en
dc.subject.lccRCen
dc.titleCo-morbidity burden in Parkinson’s disease : Comparison with controls and its influence on prognosisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Chronic Disease Research Groupen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Data Safe Havenen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.description.versionPostprinten
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1016/j.parkreldis.2016.05.013


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record